MedTrace Logo

A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency

NCT02301026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2017-06-14

No results posted yet for this study

Summary

The purpose of the study is to monitor initiated Diafer® therapy administered according to hospital practice and the product labeling in routine clinical practice in haemodialysis patients with Chronic Kidney Disease.

Conditions

  • Anaemia in Chronic Kidney Disease

Interventions

DRUG

5% Iron Isomaltoside 1000

Administered according to local routines and product labeling in doses at the doctors discretion

Sponsors & Collaborators

  • BioStata

    collaborator INDUSTRY

  • Pharmacosmos A/S

    lead INDUSTRY

Principal Investigators

  • Sylvia Simon · Pharmacosmos A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2016-12-09
Completion
2016-12-09

Countries

  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301026 on ClinicalTrials.gov